Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders

Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders

US Patent 11505539 · Granted Nov 22, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2025
Heterocyclic acyl hydrazone linkers, methods and uses thereof2023
Acyl hydrazone linkers, methods and uses thereof2023
Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein int2022
Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein int2022
Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein int2022
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2022
Substituted carboxamides as inhibitors of WDR5 protein-protein binding2022
Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses2022
Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses2022
Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses2022